A citation-based method for searching scientific literature

Kurt D Christensen, Jason Karlawish, J Scott Roberts, Wendy R Uhlmann, Kristin Harkins, Elisabeth M Wood, Thomas O Obisesan, Lan Q Le, L Adrienne Cupples, Emilie S Zoltick, Megan S Johnson, Margaret K Bradbury, Leo B Waterston, Clara A Chen, Sara Feldman, Denise L Perry, Robert C Green. Alzheimers Dement (N Y) 2020
Times Cited: 7







List of co-cited articles
8 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Disclosure of APOE genotype for risk of Alzheimer's disease.
Robert C Green, J Scott Roberts, L Adrienne Cupples, Norman R Relkin, Peter J Whitehouse, Tamsen Brown, Susan LaRusse Eckert, Melissa Butson, A Dessa Sadovnick, Kimberly A Quaid,[...]. N Engl J Med 2009
313
57

Health behavior changes after genetic risk assessment for Alzheimer disease: The REVEAL Study.
Serena Chao, J Scott Roberts, Theresa M Marteau, Rebecca Silliman, L Adrienne Cupples, Robert C Green. Alzheimer Dis Assoc Disord 2008
156
42

A new scale measuring psychologic impact of genetic susceptibility testing for Alzheimer disease.
Winston W Chung, Clara A Chen, L Adrienne Cupples, J Scott Roberts, Susan C Hiraki, Anil K Nair, Robert C Green, Robert A Stern. Alzheimer Dis Assoc Disord 2009
19
28

Disclosure of amyloid PET scan results: A systematic review.
Hyejin Kim, Jennifer H Lingler. Prog Mol Biol Transl Sci 2019
6
33

Disclosure of amyloid positron emission tomography results to individuals without dementia: a systematic review.
Arno de Wilde, Marieke M van Buchem, René H J Otten, Femke Bouwman, Andrew Stephens, Frederik Barkhof, Philip Scheltens, Wiesje M van der Flier. Alzheimers Res Ther 2018
19
28

Alzheimer's disease prevention: from risk factors to early intervention.
Marta Crous-Bou, Carolina Minguillón, Nina Gramunt, José Luis Molinuevo. Alzheimers Res Ther 2017
150
28

A Survey of Knowledge and Views Concerning Genetic and Amyloid PET Status Disclosure.
B R Ott, M A Pelosi, G Tremont, P J Snyder. Alzheimers Dement (N Y) 2016
15
28

Cognitively unimpaired adults' reactions to disclosure of amyloid PET scan results.
Emily A Largent, Kristin Harkins, Christopher H van Dyck, Sara Hachey, Pamela Sankar, Jason Karlawish. PLoS One 2020
17
28

A validity and reliability study of the coping self-efficacy scale.
Margaret A Chesney, Torsten B Neilands, Donald B Chambers, Jonelle M Taylor, Susan Folkman. Br J Health Psychol 2006
230
14

Development of a Standardized Approach to Disclosing Amyloid Imaging Research Results in Mild Cognitive Impairment.
Jennifer H Lingler, Meryl A Butters, Amanda L Gentry, Lu Hu, Amanda E Hunsaker, William E Klunk, Meghan K Mattos, Lisa S Parker, J Scott Roberts, Richard Schulz. J Alzheimers Dis 2016
22
14

The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease.
Marilyn S Albert, Steven T DeKosky, Dennis Dickson, Bruno Dubois, Howard H Feldman, Nick C Fox, Anthony Gamst, David M Holtzman, William J Jagust, Ronald C Petersen,[...]. Alzheimers Dement 2011
14

Cerebral PET with florbetapir compared with neuropathology at autopsy for detection of neuritic amyloid-β plaques: a prospective cohort study.
Christopher M Clark, Michael J Pontecorvo, Thomas G Beach, Barry J Bedell, R Edward Coleman, P Murali Doraiswamy, Adam S Fleisher, Eric M Reiman, Marwan N Sabbagh, Carl H Sadowsky,[...]. Lancet Neurol 2012
478
14

Disclosure of amyloid imaging results to research participants: has the time come?
Jennifer H Lingler, William E Klunk. Alzheimers Dement 2013
29
14

Impact of Event Scale: a measure of subjective stress.
M Horowitz, N Wilner, W Alvarez. Psychosom Med 1979
14

Update on appropriate use criteria for amyloid PET imaging: dementia experts, mild cognitive impairment, and education. Amyloid Imaging Task Force of the Alzheimer’s Association and Society for Nuclear Medicine and Molecular Imaging.
Keith A Johnson, Satoshi Minoshima, Nicolaas I Bohnen, Kevin J Donohoe, Norman L Foster, Peter Herscovitch, Jason H Karlawish, Christopher C Rowe, Saima Hedrick, Virginia Pappas,[...]. Alzheimers Dement 2013
57
14

Amyloid positron emission tomography candidates may focus more on benefits than risks of results disclosure.
Jennifer H Lingler, J Scott Roberts, Hyejin Kim, Jonna L Morris, Lu Hu, Meghan Mattos, Eric McDade, Oscar L Lopez. Alzheimers Dement (Amst) 2018
5
20

Appropriate use criteria for amyloid PET: a report of the Amyloid Imaging Task Force, the Society of Nuclear Medicine and Molecular Imaging, and the Alzheimer's Association.
Keith A Johnson, Satoshi Minoshima, Nicolaas I Bohnen, Kevin J Donohoe, Norman L Foster, Peter Herscovitch, Jason H Karlawish, Christopher C Rowe, Maria C Carrillo, Dean M Hartley,[...]. Alzheimers Dement 2013
274
14

Research Use of Ecological Momentary Assessment for Adverse Event Monitoring Following Amyloid-β Results Disclosure.
Meghan K Mattos, Susan M Sereika, Scott R Beach, Hyejin Kim, William E Klunk, Melissa Knox, Neelesh K Nadkarni, Lisa S Parker, J Scott Roberts, Richard Schulz,[...]. J Alzheimers Dis 2019
4
25

Added value of amyloid PET in individualized risk predictions for MCI patients.
Ingrid S van Maurik, Laura M van der Kall, Arno de Wilde, Femke H Bouwman, Philip Scheltens, Bart N M van Berckel, Johannes Berkhof, Wiesje M van der Flier. Alzheimers Dement (Amst) 2019
4
25

The APOE-epsilon4 allele and the risk of Alzheimer disease among African Americans, whites, and Hispanics.
M X Tang, Y Stern, K Marder, K Bell, B Gurland, R Lantigua, H Andrews, L Feng, B Tycko, R Mayeux. JAMA 1998
511
14

Neuropsychological function and apolipoprotein E genotype in the preclinical detection of Alzheimer's disease.
M W Bondi, D P Salmon, D Galasko, R G Thomas, L J Thal. Psychol Aging 1999
171
14

Successful use of whole genome amplified DNA from multiple source types for high-density Illumina SNP microarrays.
Casey L Dagnall, Lindsay M Morton, Belynda D Hicks, Shengchao Li, Weiyin Zhou, Eric Karlins, Kedest Teshome, Salma Chowdhury, Kerrie S Lashley, Joshua N Sampson,[...]. BMC Genomics 2018
9
14

Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy.
Chia-Chen Liu, Chia-Chan Liu, Takahisa Kanekiyo, Huaxi Xu, Guojun Bu. Nat Rev Neurol 2013
14

Healthybrains.org: From Registry to Randomization.
K Zhong, J Cummings. J Prev Alzheimers Dis 2016
7
14

APOE genotype and cognition in healthy individuals at risk of Alzheimer's disease: A review.
M Clare O'Donoghue, Susannah E Murphy, Giovanna Zamboni, Anna C Nobre, Clare E Mackay. Cortex 2018
51
14

The impact of APOE genotype on survival: Results of 38,537 participants from six population-based cohorts (E2-CHARGE).
Frank J Wolters, Qiong Yang, Mary L Biggs, Johanna Jakobsdottir, Shuo Li, Daniel S Evans, Joshua C Bis, Tamara B Harris, Ramachandran S Vasan, Nuno R Zilhao,[...]. PLoS One 2019
19
14

Efficient replication of over 180 genetic associations with self-reported medical data.
Joyce Y Tung, Chuong B Do, David A Hinds, Amy K Kiefer, J Michael Macpherson, Arnab B Chowdry, Uta Francke, Brian T Naughton, Joanna L Mountain, Anne Wojcicki,[...]. PLoS One 2011
80
14

Comparison of cognitive functioning as measured by the Ruff Figural Fluency Test and the CogState computerized battery within the LifeLines Cohort Study.
Jisca S Kuiper, Richard C Oude Voshaar, Floor E A Verhoeven, Sytse U Zuidema, Nynke Smidt. BMC Psychol 2017
10
14

Prevalence of cerebral amyloid pathology in persons without dementia: a meta-analysis.
Willemijn J Jansen, Rik Ossenkoppele, Dirk L Knol, Betty M Tijms, Philip Scheltens, Frans R J Verhey, Pieter Jelle Visser, Pauline Aalten, Dag Aarsland, Daniel Alcolea,[...]. JAMA 2015
732
14

APOE ε4 moderates amyloid-related memory decline in preclinical Alzheimer's disease.
Yen Ying Lim, Victor L Villemagne, Robert H Pietrzak, David Ames, Kathryn A Ellis, Karra Harrington, Peter J Snyder, Ralph N Martins, Colin L Masters, Christopher C Rowe,[...]. Neurobiol Aging 2015
50
14

Lack of reliable evidence for a distinctive ε4-related cognitive phenotype that is independent from clinical diagnostic status: findings from the Australian Imaging, Biomarkers and Lifestyle Study.
Jonathan K Foster, Matthew A Albrecht, Greg Savage, Nicola T Lautenschlager, Kathryn A Ellis, Paul Maruff, Cassandra Szoeke, Kevin Taddei, Ralph Martins, Colin L Masters,[...]. Brain 2013
22
14


Impacts of apolipoprotein E disclosure on healthy Asian older adults: a cohort study.
Wei Theng Sng, Si Ning Yeo, Bernice Xiangting Lin, Tih-Shih Lee. Int Psychogeriatr 2019
2
50

Unsupervised online neuropsychological test performance for individuals with mild cognitive impairment and dementia: Results from the Brain Health Registry.
R Scott Mackin, Philip S Insel, Diana Truran, Shannon Finley, Derek Flenniken, Rachel Nosheny, Aaron Ulbright, Monica Comacho, David Bickford, Brian Harel,[...]. Alzheimers Dement (Amst) 2018
28
14

GeneMatch: A novel recruitment registry using at-home APOE genotyping to enhance referrals to Alzheimer's prevention studies.
Jessica B Langbaum, Jason Karlawish, J Scott Roberts, Elisabeth M Wood, Angela Bradbury, Nellie High, Trisha L Walsh, David Gordon, Raj Aggarwal, Peter Davis,[...]. Alzheimers Dement 2019
15
14

Web-based, participant-driven studies yield novel genetic associations for common traits.
Nicholas Eriksson, J Michael Macpherson, Joyce Y Tung, Lawrence S Hon, Brian Naughton, Serge Saxonov, Linda Avey, Anne Wojcicki, Itsik Pe'er, Joanna Mountain. PLoS Genet 2010
275
14

Attitudes of Research Participants and the General Public Regarding Disclosure of Alzheimer Disease Research Results.
Jonathan Gooblar, Catherine M Roe, Natalie J Selsor, Matthew J Gabel, John C Morris. JAMA Neurol 2015
19
14

The Brain Health Registry: An internet-based platform for recruitment, assessment, and longitudinal monitoring of participants for neuroscience studies.
Michael W Weiner, Rachel Nosheny, Monica Camacho, Diana Truran-Sacrey, R Scott Mackin, Derek Flenniken, Aaron Ulbricht, Philip Insel, Shannon Finley, Juliet Fockler,[...]. Alzheimers Dement 2018
38
14

Clustering of 770,000 genomes reveals post-colonial population structure of North America.
Eunjung Han, Peter Carbonetto, Ross E Curtis, Yong Wang, Julie M Granka, Jake Byrnes, Keith Noto, Amir R Kermany, Natalie M Myres, Mathew J Barber,[...]. Nat Commun 2017
35
14

Comparison of Cognitive Performance on the Cogstate Brief Battery When Taken In-Clinic, In-Group, and Unsupervised.
Jason A Cromer, Brian T Harel, Karen Yu, Jaclyn S Valadka, Jack W Brunwin, Cameron D Crawford, Linda C Mayes, Paul Maruff. Clin Neuropsychol 2015
30
14

The Wisconsin Registry for Alzheimer's Prevention: A review of findings and current directions.
Sterling C Johnson, Rebecca L Koscik, Erin M Jonaitis, Lindsay R Clark, Kimberly D Mueller, Sara E Berman, Barbara B Bendlin, Corinne D Engelman, Ozioma C Okonkwo, Kirk J Hogan,[...]. Alzheimers Dement (Amst) 2017
75
14

Public perceptions of presymptomatic testing for Alzheimer disease.
Richard J Caselli, Jessica Langbaum, Gary E Marchant, Rachel A Lindor, Katherine S Hunt, Bruce R Henslin, Amylou C Dueck, Jason S Robert. Mayo Clin Proc 2014
32
14

APOE ε2ε4 genotype, incident AD and MCI, cognitive decline, and AD pathology in older adults.
Shahram Oveisgharan, Aron S Buchman, Lei Yu, Jose Farfel, Vladimir Hachinski, Chris Gaiteri, Philip L De Jager, Julie A Schneider, David A Bennett. Neurology 2018
20
14


Apolipoprotein E genotype and cardiovascular disease in the Framingham Heart Study.
C Lahoz, E J Schaefer, L A Cupples, P W Wilson, D Levy, D Osgood, S Parpos, J Pedro-Botet, J A Daly, J M Ordovas. Atherosclerosis 2001
212
14


Alzheimer disease genetic risk factor APOE e4 and cognitive abilities in 111,739 UK Biobank participants.
Donald M Lyall, Joey Ward, Stuart J Ritchie, Gail Davies, Breda Cullen, Carlos Celis, Mark E S Bailey, Jana Anderson, Jon Evans, Daniel F Mckay,[...]. Age Ageing 2016
16
14

Posttraumatic stress disorder symptoms and cognitive function in a large cohort of middle-aged women.
Jennifer A Sumner, Kaitlin Hagan, Fran Grodstein, Andrea L Roberts, Brian Harel, Karestan C Koenen. Depress Anxiety 2017
34
14

Constructing a Local Potential Participant Registry to Improve Alzheimer's Disease Clinical Research Recruitment.
Joshua D Grill, Dan Hoang, Daniel L Gillen, Chelsea G Cox, Adrijana Gombosev, Kirsten Klein, Steve O'Leary, Megan Witbracht, Aimee Pierce. J Alzheimers Dis 2018
17
14

Genetic Sample Provision Among National Alzheimer's Coordinating Center Participants.
Shoshana H Bardach, Gregory A Jicha, Shama Karanth, Xuan Zhang, Erin L Abner. J Alzheimers Dis 2019
2
50


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.